Tauns Laboratories Inc
TSE:197A
Relative Value
The Relative Value of one
197A
stock under the Base Case scenario is
437.02
JPY.
Compared to the current market price of 532 JPY,
Tauns Laboratories Inc
is
Overvalued by 18%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
197A Competitors Multiples
Tauns Laboratories Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Tauns Laboratories Inc
TSE:197A
|
56.6B JPY | 3.8 | 15.3 | 12.7 | 14.6 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.2 | 37.5 | 27.1 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
54.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.8B CHF | 3.7 | 39 | 15 | 29.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
101.3B DKK | 3.7 | 25.6 | 13.4 | 16 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.7B USD | 2.9 | 28.6 | 12.3 | 16.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.6 | 36 | 14.3 | 24.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.8B CNY | 9.2 | 25.3 | 22.8 | 22.8 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 1.1 | -15.9 | 17 | 55.2 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD | 3.3 | 21.9 | 14 | 17.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
819.6B JPY | 6.3 | 46.3 | 21.8 | 29.6 |